Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials

References

• Ascher B, Hoffmann K, Walker P, et al. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol 2014;28:1707–1715.
   PubMed Web of Science ®Google Scholar
• Ascher B, Fellmann J, Monheit G. ATX-101 (deoxycholic acid injection) for reduction of submental fat. Expert Rev Clin Pharmacol 2016;9:1131–1143.
   PubMed Web of Science ®Google Scholar
• Glogau RG, Glaser DA, Callender VD, et al. A double-blind, placebo-controlled, phase 3b study of ATX-101 for reduction of mild or extreme submental fat. Dermatol Surg 2019;45:1531–1541. .
   PubMed Web of Science ®Google Scholar
• Jones DH, Carruthers J, Joseph JH, et al. REFINE- 1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with atx-101, an injectable drug for submental fat reduction. Dermatol Surg 2016;42:38–49.
   PubMed Web of Science ®Google Scholar
• Rzany B, Griffiths T, Walker P, et al. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol 2014;170:445–453 .
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh M, Nasrfard S, Nezafati P, et al. Effects of radio frequency and ultrasound cavitation therapy on serum c-reactive protein and pro-oxidant-antioxidant levels. Arch Iran Med 2016;19:348–352.
   PubMed Web of Science ®Google Scholar
• Arabpour-Dahoue M, Mohammadzadeh E, Avan A, et al. Leptin level decreases after treatment with the combination of Radiofrequency and Ultrasound cavitation in response to the reduction in adiposity. Diabetes Metab Syndr 2019;13:1137–1140.
   PubMed Web of Science ®Google Scholar
• Meyer PF, Furtado ACG, Morais SFT, et al. Effects of cryolipolysis on abdominal adiposity of women. Cryo Letters 2017;38:379–386.
   PubMed Web of Science ®Google Scholar
• Bernstein EF, Bloom JD Safety and efficacy of bilateral submental cryolipolysis with quantified 3-dimensional imaging of fat reduction and skin tightening. JAMA Facial Plast Surg 2017;19:350–357.
   PubMed Web of Science ®Google Scholar
• Humphrey S, Sykes J, Kantor J, et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol. 2016;75:788–797.e7.
   Google Scholar
• Thuangtong R, Bentow JJ, Knopp K, et al. Tissue-selective effects of injected deoxycholate. Dermatol Surg 2010;36:899–908.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535–b2535.
   PubMed Web of Science ®Google Scholar
• Munnangi S, Angus LD Placebo effect. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [cited 2020 Jul 27]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK513296/.
   Google Scholar
• Dover JS, Kenkel JM, Carruthers A, et al. Management of patient experience with ATX-101 (Deoxycholic Acid Injection) for reduction of submental fat. Dermatol Surg. 2016;42 Suppl 1:S288–S299.
   PubMedGoogle Scholar
• Humphrey S Management of patient experience with ATX-101 (Deoxycholic Acid Injection) for reduction of submental fat. Dermatol Surg 2016;42:1397–1398.
   PubMedGoogle Scholar
• Rauso R Deoxycholate (ATX-101) mixed with lidocaine to minimize pain/discomfort in nonsurgical treatment of submental fullness appearance. J Cutan Aesthet Surg 2018;11:229–233.
   PubMedGoogle Scholar
• Hexsel D, Soirefmann M, Donida Porto M, et al. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds: Dermatol Surg 2012;38:207–214.
   PubMed Web of Science ®Google Scholar
• Fulton J, Caperton C, Weinkle S, et al. Filler injections with the blunt-tip microcannula. J Drugs Dermatol 2012;11:1098–1103.
   PubMed Web of Science ®Google Scholar
• Rauso R, Salti GACE Marked drug used for localized adiposity reduction: a 4-year experience. Aesthet Surg J 2015;35:850–857.
   PubMed Web of Science ®Google Scholar
• McDiarmid J, Ruiz JB, Lee D, et al. Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat. Aesthetic Plast Surg 2014;38:849–860.
   PubMed Web of Science ®Google Scholar
• Walker PS, Lee DR, Toth BA, et al. Histological analysis of the effect of ATX-101 (Deoxycholic Acid Injection) on subcutaneous fat: results from a phase 1 open-label study. Dermatol Surg 2020;46:70–77.
   PubMed Web of Science ®Google Scholar
• Souyoul S, Gioe O, Emerson A, et al. Alopecia after injection of ATX-101 for reduction of submental fat. JAAD Case Rep 2017;3:250–252.
   PubMedGoogle Scholar
• Sebaratnam DF, Wong XL, Kim L, et al. Alopecia following deoxycholic acid treatment for submental adiposity. JAMA Facial Plast Surg 2019;21:571–572.
   PubMed Web of Science ®Google Scholar
• Riswold K, Flynn V, Cautionary Tale A, et al. With deoxycholic acid injection. Dermatol Surg 2018;44:887–889.
   PubMed Web of Science ®Google Scholar
• McKay C, Price C, Pruett L vascular injury after deoxycholic acid injection. Dermatol Surg 2019;45:306–309.
   PubMed Web of Science ®Google Scholar
• Lindgren AL, Welsh KM Inadvertent intra-arterial injection of deoxycholic acid: a case report and proposed protocol for treatment. J Cosmet Dermatol 2019 10.1111/jocd.13214.
   PubMed Web of Science ®Google Scholar
• Sachdev D, Mohammadi T, Fabi SG Deoxycholic acid-induced skin necrosis: prevention and management. Dermatol Surg 2018;44:1037–1039.
   PubMed Web of Science ®Google Scholar
• Beer K, Glogau RG, Dover JS, et al. A randomized, evaluator-blinded, controlled study of effectiveness and safety of small particle hyaluronic acid plus lidocaine for lip augmentation and perioral rhytides. Dermatol Surg. 2015;41 Suppl 1:S127–136.
   PubMedGoogle Scholar